Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2000
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354543A1 Compositions and methods for the treatment of anorectal disorders
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1009769A1 N-terminal modifications of rantes and methods of use
06/21/2000EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
06/21/2000EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000EP1009431A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
06/21/2000EP1009425A1 Wound healing
06/21/2000EP1009421A1 Methods and compositions for enhanced wound healing
06/21/2000EP1009398A1 Molecular complex and control-release of alpha hydroxyacids
06/21/2000EP1009380A1 Method for preparing pharmaceutical formulations
06/21/2000EP1009379A1 Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins
06/21/2000EP1009378A1 Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology
06/21/2000EP1009377A1 Medical uses of pyruvates
06/21/2000EP1009345A1 Skin aging and wound treatment using cell migration agents
06/21/2000DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors
06/21/2000CN1257539A Short peptides which selectively modulate intracellular signalling
06/21/2000CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases
06/21/2000CN1257503A 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo (3,2-D] pyrimidine-4-ones
06/21/2000CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1256949A Hongchanjinu (liquid) soluble granules
06/21/2000CN1256944A Multi-function monosaccharidase medicinal composition
06/21/2000CN1256939A Oral liquid for promoting growth of hair
06/21/2000CN1256928A Skin-cleaning medicine (Jiefuning)
06/21/2000CN1256927A Skin-cleaning sterilizing agent (Ziguang oil)
06/21/2000CN1256916A 9-cis-retinonic acid and medicinal use of salt and ester thereof
06/21/2000CN1256914A Skin brightening composition containing Arctostaphylos ura-ursi extract and reductant
06/21/2000CN1256912A Macule-removing skin-whitening cosmetics containing hydroquinone monopropionate fat and alpha-hydroxy acid
06/21/2000CN1053588C Method for preparation of pills for growing and blackening hair
06/21/2000CN1053586C Ointment for treating scald
06/21/2000CN1053580C Medicine for treating psoriasis
06/21/2000CN1053577C Medicinal powder for treating burn and scald
06/21/2000CN1053573C Traditional Chinese medicine ointment for curing burns and preparing method
06/20/2000US6077520 Cosmetic composition
06/20/2000US6077503 Skin whitener composition containing mercaptodextran
06/20/2000CA2144845C Germicidal detergent-iodine compositions having reduced detergent content
06/20/2000CA1341029C Peptidase inhibitors
06/17/2000CA2290880A1 Cosmetic skin care compositions containing succinate compounds
06/15/2000WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders
06/15/2000WO2000034459A1 Animal model for psoriasis for the prevention and treatment of psoriasis in humans
06/15/2000WO2000034313A1 Procollagen c-proteinase inhibitors
06/15/2000WO2000034303A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR α-INDUCED EXPRESSION OF CELL ADHESION MOLECULES
06/15/2000WO2000034281A1 Methotrexate derivatives
06/15/2000WO2000034258A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
06/15/2000WO2000034254A1 Novel compounds
06/15/2000WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000WO2000034246A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative
06/15/2000WO2000034245A2 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase
06/15/2000WO2000034228A1 Ion channel modulating agents
06/15/2000WO2000033894A1 Collagen hemostatic foam
06/15/2000WO2000033893A1 Sterile complex of therapeutic peptide bond to a polysaccharide
06/15/2000WO2000033876A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
06/15/2000WO2000033842A1 Myt1 kinase inhibitors
06/15/2000WO2000033841A1 Myt1 kinase inhibitors
06/15/2000WO2000033838A1 Vitronectin receptor antagonist
06/15/2000WO2000033837A2 Myt1 kinase inhibitors
06/15/2000WO2000033834A1 Use of isatin derivatives as ion channel activating agents
06/15/2000WO2000033787A2 Deodorant cosmetic composition
06/15/2000WO2000006604A3 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases
06/15/2000WO2000003748A3 Compositions which contain triterpenes for regulating hair growth
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000DE19857009A1 Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren Preparation with improved therapeutic index containing nucleotide synthesis
06/15/2000CA2354644A1 Muc-1 antagonists and methods of treating immune disorders
06/15/2000CA2354266A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
06/15/2000CA2354022A1 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase
06/15/2000CA2354021A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative
06/15/2000CA2353839A1 Methotrexate derivatives
06/15/2000CA2353721A1 Deodorant cosmetic composition
06/15/2000CA2353415A1 Vitronectin receptor antagonist
06/15/2000CA2352740A1 Procollagen c-proteinase inhibitors
06/15/2000CA2350767A1 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
06/15/2000CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/14/2000EP1007645A1 Human serum inducible kinase (snk)
06/14/2000EP1007555A1 Tropoelastin derivatives
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007534A1 Bh3 interacting domain death agonist
06/14/2000EP1007533A1 Bioconjugates and delivery of bioactive agents
06/14/2000EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
06/14/2000EP1007090A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
06/14/2000EP1007080A1 Sustained peptide-release formulation
06/14/2000EP1007065A1 Preparation of collagen
06/14/2000EP1007062A1 Therapeutic use of hemoglobin to treat head injury
06/14/2000EP1007047A1 Use of mizolastine for preparing a medicine for treating inflammation
06/14/2000EP1007045A1 Topical application of opioid analgesic drugs such as morphine
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007020A1 Treatment of cell-mediated immune diseases
06/14/2000EP1006996A1 USE OF 17-$g(a)-ESTRADIOL FOR THE TREATMENT OF AGED OR SUNDAMAGED SKIN AND/OR SKIN ATROPHY
06/14/2000EP0822812A4 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines
06/14/2000CN1256141A Itching-stopping chili liquid and its preparation
06/14/2000CN1256138A Pain-relieving and inflammation-diminishing medicine powder for burn and scald
06/14/2000CN1256130A Scald-treating fumigation roll
06/14/2000CN1256122A Hair loss preventing plant shampoo
06/14/2000CN1256120A Natural medicine as hair restorer
06/14/2000CN1053373C Ointment for treatment of psoriasis and prep. thereof
06/14/2000CN1053372C Tinea lotion
1 ... 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 ... 1065